Treatment: Zolpidem (Ambien)

Use these Health Check-up tools to learn more

Zolpidem (Ambien)

Zolpidem (Ambien) is a sedative-hypnotic medication that is used to treat difficulty sleeping. Zolpidem is the generic name for the brand-name drug Ambien. Zolpidem/Ambien is usually used to treat insomnia, which can cause difficulty falling asleep or difficulty remaining asleep. Zolpidem/Ambien slows down the brain's activity to help you sleep. Zolpidem/Ambien is available in regular and extended-release tablet forms, as well as an oral spray. Zolpidem/Ambien can make you feel very sleepy shortly after taking the medication and for as long as seven to eight hours afterward. If you don't get sufficient sleep after taking zolpidem/Ambien, you may feel confused or have difficulty with memory.

Zolpidem (Ambien) is most frequently used to treat the following conditions by our membersLogin to add your rating >

EN-US::CST:POPULARSIDEEFFECTSLogin to add your rating >

  • How effective?
    How common?
    Description

People near you using the same treatments

People near you using the same treatments

Treatment Symptom Age Gender

Read what others are saying about Zolpidem (Ambien)

There are no comments yet. Be the first

Join the conversation

You must be a member to join the conversation.

Join now for FREE to learn and share about your condition with other members

advertisement
V2012.311.925.327
Last updated on Apr 30 2012 at 16:16
Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.